Zentalis Pharmaceuticals, Inc. (NasdaqGM: ZNTL)
Health Care · Biotechnology · US
$2.51
-0.40% today · +58.5% 1Y
Zentalis Pharmaceuticals, Inc. (NasdaqGM: ZNTL) operates in the Biotechnology industry within the Health Care sector. The company is valued at $238.57M and employs 106 people.
Over the last twelve months the share price has gained 58.5%, trading between 1.21 and 6.95.
Tweenvest scores Zentalis Pharmaceuticals, Inc. across four factors: quality 38/100, value 42/100. Its strongest factor is value.
ZNTL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $238.57M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.96
- Dividend yield
- —
- Beta (5Y)
- 1.94
- 52-week high
- $6.95
- 52-week low
- $1.21
- Avg volume (3M)
- —
- Shares outstanding
- 94.67M
- Employees
- 106
- Next earnings
- —
About Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.
- ISIN
- US98943L1070
- Founded
- 2014
- Listed since
- Apr 3, 2020
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Oryzon Genomics S.A.BME: ORY | $241.39M | €2.63 | -2.59% |
| PegBio Co., Ltd.SEHK: 2565 | $241.22M | HK$4.84 | -9.70% |
| Shandong Boan Biotechnology Co., Ltd.SEHK: 6955 | $240.30M | HK$3.03 | +9.39% |
| Akebia Therapeutics, Inc.NasdaqCM: AKBA | $239.70M | $0.81 | -5.80% |
| Adimmune CorporationTWSE: 4142 | $238.18M | NT$18.00 | +0.56% |
| Tetratherix LimitedASX: TTX | $237.86M | AU$6.45 | +4.03% |
| Lineage Cell Therapeutics, Inc.NYSEAM: LCTX | $235.28M | $1.03 | +10.72% |
| Acepodia, Inc.TPEX: 6976 | $234.21M | NT$12.80 | -0.78% |
Figures last refreshed Oct 4, 2026.